Paxil eases depression but not fatigue in patients getting chemotherapy

May 11, 2001

A commonly used antidepressant significantly relieves depression in cancer patients undergoing chemotherapy, but has less effect on fatigue, according to a study led by University of Rochester Medical Center researcher Gary Morrow, Ph.D.

Results of the study, sponsored by the National Cancer Institute and conducted by community physicians nationwide, suggest that fatigue in these patients may be more related to a patient's cancer and its treatment, rather than depression. Morrow will present the results Monday at the annual meeting of the American Society of Clinical Oncology in San Francisco.

Previous studies in the general population and several surveys of cancer patients have associated depression with increased fatigue, and animal models of low serotonin levels have also demonstrated a common link. But, in this study, researchers found that while Paxil significantly alleviated depression, the drug's effect on fatigue was not significant.

"Our results show that depression and fatigue do not seem as closely related in cancer patients as we once thought, especially in patients receiving chemotherapy," said Morrow, a professor of radiation oncology and psychiatry. "This study demonstrates we can successfully treat depression in cancer patients, but an effective intervention for fatigue remains to be shown."

In the double-blind study funded by the National Cancer Institute, 738 patients being treated in 18 different private medical oncology practices affiliated with the Community Clinical Oncology Program Research Base at the University of Rochester Medical Center were assigned to receive either a 20 mg daily dose of paroxetine hydrochloride (Paxil), a selective serotonin re-uptake inhibitor, or a placebo. Patients were then asked to fill out questionnaires on mood and functioning.

Depression is associated with a decreased amount of serotonin in the brain, which helps regulate mood. Paxil blocks the reabsorption of serotonin and normalizes the brain's chemical supply.

According to Morrow, "Up to half of cancer patients may experience some degree of depression during the course of their diagnosis, treatment and recovery, and the condition has not been optimally treated. We found that it can be successfully treated by medical oncologists who treat patients in the community."
-end-


University of Rochester Medical Center

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.